Dmitry Balyasny’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-11,381
Closed -$26K 2398
2018
Q1
$26K Sell
11,381
-3,319
-23% -$7.77K ﹤0.01% 1875
2017
Q4
$43K Buy
+14,700
New +$40.6K ﹤0.01% 2017
2017
Q1
Sell
-10,300
Closed -$18K 1916
2016
Q4
$18K Buy
+10,300
New +$21K ﹤0.01% 1327
2016
Q1
Sell
-37,130
Closed -$178K 1738
2015
Q4
$178K Sell
37,130
-503,286
-93% -$2.85M ﹤0.01% 1106
2015
Q3
$3M Buy
+540,416
New +$3.99M 0.02% 610

Other funds holding BDSI

Dmitry Balyasny's BDSI Position: Q2 2018 in Review

Dmitry Balyasny sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2018, closing a stake of 11,381 shares — an estimated $26K sold.

Dmitry Balyasny first reported a position in BDSI in Q3 2015 and held it in 5 quarters. The position peaked at $3M in Q3 2015. 68 funds tracked by Wall St. Rank hold BDSI as of Q2 2018.

  • Dmitry Balyasny reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2018 after selling out during the quarter.
  • Dmitry Balyasny sold 11,381 BioDelivery Sciences International, Inc. shares in Q2 2018, an estimated $26K.
  • Dmitry Balyasny first reported a position in BioDelivery Sciences International, Inc. in Q3 2015 and held it in 5 quarters.
  • Dmitry Balyasny's BioDelivery Sciences International, Inc. position peaked at $3M in Q3 2015.
  • 68 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2018.

Based on Balyasny Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.